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Mutagenic Efficiency of Organophosphorus
Insecticides Used in Combined Treatments
by Noel Degraeve,* Marie-Christine Chollet,* and
Jean Moutschent
Malemice(Qstrain)receivedtwoconsecutive injectionsoforganophosphorus insecticides: aphosphonate
(trichlorfon) was combined to a thiophosphate (methylparathion) or a dithiophosphate (malathion or
methylazinphos) in order to evaluate the interactions at the genetic and cytogenetic levels.
No increase in chromosome damage was observed in bone marrow cells, spermatogonia, and primary
spermatocytes. In a dominant lethal mutation assay, the frequency of postimplantation lethality was not
significantly increased over the control level. The percentage of preimplantation losses was enhanced,
probably due to a toxic effect on male germ cells.
Introduction
The toxic effects induced by an organophosphorus
insecticide can sometimes be modified by the action of
another compound ofthe same group. Synergism occurs
between trichlorfon and malathion or trichlorfon and
methylazinphos. In contrast, there is an antagonism
between malathion and parathion or malathion and
methylazinphos (1,2). The potentiation of anticholines-
terase action is explained bythe inhibition ofcarboxyes-
terase and carboxyamidase which detoxify the pesti-
cides. Thefirstcompoundcompeteswiththedetoxifying
enzyme, impeding hydrolysis ofthe other, which results
in a protracted action (3). These properties explain the
increasing number of complex commercial insecticides
which contain more than one active substance. The
purpose of such associations is to produce both a
simultaneous control of several pests and a toxicity
potentiation.
On the other hand, some organophosphorus pesti-
cides can induce mutations in microorganisms but most
ofthem are generally ineffective in mammals treated in
vivo (4).
The purpose of the present study is to evaluate the
possibility of synergisms for cytogenetic (chromosome
damage in bone marrow cells, spermatogonia and
primary spermatocytes) and genetic (dominant lethal
mutations) effects induced in mice after acute in vivo
treatments.
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Treatments were performed, combining phosphonate
(trichlorfon) and athiophosphate (methylparathion) ora
dithiophosphate (malathion or methylazinphos). The
results obtained with these four compounds tested
separately have been reported elsewhere (5-8).
Materials and Methods
The four organophosphorus compounds, trichlorfon
(dimethyl 1-hydroxy-2,2,2-trichloroethyl phosphonate),
methylparathion (dimethyl p-nitrophenyl phosphoro-
thionate), malathion [dimethyl S-(1,2 diethoxycarba-
moylethyl) phosphorothionothiolate], and methylazin-
phos [dimethyl S-(4-oxobenzotriazino-3-methyl) phos-
phorothionothiolate] were Riedel-De Haen products,
guaranteed 99% pure(Pestanal). Solutions areprepared
extemporaneously.
In combined treatments, the two compounds were
injected consecutively. Control and treated groups were
tested concurrently. The insecticides were tested at the
highest tolerated doses (trichlorfon, 100 mg/kg; methyl-
parathion, 10 mg/kg; malathion, 300 mg/kg; methyla-
zinphos, 1 mg/kg), or were decreased by 50% in
combined treatments.
For the genetic and cytogenetic assays, 25 three- to
four-month old male mice (Q strain) in each treated
group received IP injections. Twenty untreated males
were used as a negative control.
Cytogenetic effects in bone marrow cells were ana-
lyzed for two animals selected using a randomization
table and sacrificed 12, 24, and 36 hr after treatment.
The same schedule was followed for spermatogonia.
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ponded to the treatment of A4-B type spermatogonia,
two males were randomly selected on a daily basis and
were sacrificed for the detection ofchromosome aberra-
tions in primary spermatocytes at diakinesis-metaphase
I.
Microscopic slides were prepared according to the air
drying method, were stained with Giemsa and perma-
nently mounted. Slides (5/animal) were coded prior to
microscopic analysis. Only well spread metaphases
(maximum of 50 bone marrow cells, 50 spermatogonia
or 100 spermatocytes per slide) were taken into
consideration.
Five males were selected for the dominant lethal as-
say. They were each mated with four untreated virgin
females which were replaced weekly for seven consec-
utive weeks. Pregnant females were killed 14 days after
the detection of vaginal plugs. The number of corpora
lutea was counted for each ovary. The number of live
embryos, deciduomas and late fetal deaths was deter-
mined foreach uterine horn. Fetal lethalityis expressed
Table 1. lTxic effects induced by trichlorfon alone and by
combined treatments.
Treatment
Trichlorfon, 100 mg/kg
Methylparathion, 10 mg/kg
Trichlorfon, 100 mg/kg
+ methylparathion, 10 mg/kg
Trichlorfon, 50 mg/kg
+ methylparathion, 5 mg/kg
Malathion, 300 mg/kg
Trichlorfon, 100 mg/kg
+ malathion, 300 mg/kg
Trichlorfon, 50 mg/kg
+ malathion, 150 mg/kg
Methylazinphos, 1 mg/kg
Trichlorfon, 100 mg/kg
+ methylazinphos, 1 mg/kg
Trichlorfon, 50 mg/kg
+ methylazinphos, 0.5 mg/kg
Mortality
No. %
0/59 0.0
5/71 7.0
6/10 60.0
1/78 1.3
0/58 0.0
9/10 90.0
4/73 5.5
0/56 0.0
7/20 35.0
0/77 0.0
as a percentage of the corpora lutea (preimplantation
losses and total mortality), or of implants (postimplan-
tation losses). Each positive result was confirmed by a
second independent experimentusingtwice the number
of animals.
Statistical analysis was carried out using the Kasten-
baum and Bowman tables and the x2 text.
Results and Discussion
Toxic Effects
A preliminary experiment was conducted to select
the appropriate doses for the cytogenetic and genetic
assays. As compared to the single treatments, a
significant enhancement ofthe toxicity was obtained for
the combined treatments (Table 1). Nevertheless, it
seems difficult to conclude that a real synergism of
Table 2. Cytogenetic effects induced in bone marrow cells by
trichlorfon alone and by combined treatments (500 metaphases
analyzed).
Rpecvery Percentage of aberrations
Treatment hr Breaks Exchanges Gaps
Control - 0.4 0.0 0.4
Trichlorfon, 100 mg/kg 12 0.6 0.0 0.6
24 0.6 0.2 0.6
36 0.0 0.0 0.4
Trichlorfon, 50 mg/kg 12 0.8 0.0 0.0
+ methylparathion, 24 0.0 0.0 0.2
5 mg/kg 36 0.6 0.0 0.0
Trichlorfon, 50 mg/kg 12 0.2 0.0 0.0
+ malathion, 150 24 0.0 0.0 0.0
mg/kg 36 0.4 0.0 0.0
Trichlorfon, 50 mg/kg 12 0.0 0.0 0.0
+ methylazinphos, 24 0.2 0.0 0.6
0.5 mg/kg 36 0.0 0.0 0.0
Table 3. Cytogenetic effects induced in spermatogonia by trichlorfon alone and by combined treatments.
Aberrations
Recovery period, Number of metaphases Breaks Exchanges Gaps
lTeatment hr analyzed No. % No. % No. %
Control 428 2 0.47 0 0.00 1 0.23
Trichlorfon, 100 mg/kg 12 317 3 0.95 0 0.00 2 0.63
24 252 0 0.00 0 0.00 2 0.79
36 346 1 0.29 0 0.00 1 0.29
Trichlorfon, 50mg/kg + methylparathion, 12 345 0 0.00 0 0.00 1 0.29
5 mg/kg 24 442 1 0.23 0 0.00 1 0.23
36 469 2 0.43 0 0.00 0 0.00
Trichlorfon, 50 mg/kg + malathion, 12 326 1 0.31 0 0.00 1 0.31
150 mg/kg 24 344 1 0.29 0 0.00 0 0.00
36 360 0 0.00 0 0.00 0 0.00
Trichlorfon, 50 mg/kg + methylazinphos, 12 274 1 0.36 0 0.00 0 0.00
0.5 mg/kg 24 262 0 0.00 0 0.00 0 0.00
36 194 0 0.00 0 0.00 0 0.00
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action took place. During the acute toxicity experi-
ments, we observed that the maximum tolerated dose
wasgenerallyclose tothe 100% lethaldose. Therefore it
was evident that adouble dose could induce more thana
Table 4. Cytogenetic effects induced at primary spermatocytes
by trichlorfon alone and by combined treatments (1000
metaphases analyzed).
Recovery Percentage of aberrations period,
Ireatment days Breaks Exchanges Gaps
Control - 0.3 0.0 0.0
Trichlorfon, 100 mg/kg 10 0.3 0.1 0.2
11 0.4 0.0 0.2
12 0.6 0.0 0.0
Trichlorfon, 50 mg/kg 10 0.1 0.0 0.0
+ methylparathion, 11 0.3 0.0 0.1
5 mg/kg 12 0.0 0.0 0.0
Trichlorfon, 50 mg/kg 10 0.5 0.0 0.0
+ malathion, 150 11 0.5 0.0 0.0
mg/kg 12 0.5 0.0 0.1
Trichlorfon, 50 mg/kg 10 0.2 0.0 0.0
+ methylazinphos, 11 0.4 0.0 0.1
0.5 mg/kg 12 0.2 0.0 0.0
Treatment
Control
Trichlorfon, 100 mg/kg
double lethality. On the other hand, the combined
treatment with 50% decreased doses was only slightly
toxic. Our results probably express more ofan additive
effect than a real synergism.
Cytogenetic Effects
Due to the increased toxicity, the combined treat-
ments were performed with the half-maximum toler-
ated dose. The number of lesions induced by the
organophosphorus compounds was too small to consider
individually as being aberrations of the chromatid and
chromosome types.
The frequency of chromosome aberrations in bone
marrow metaphases was not higher in treated males
than in untreated controls (Table 2). In spermatogonia
(Table 3), the percentage of chromosome lesions was
higher after trichlorfon single treatment than after the
combined treatments.
The same conclusion was reached for diakinesis
(Table4). Forthe threetest systems, we did not observe
a statistically significant difference between the treated
groups and the negative control group, or between
the combined treatment and the single trichlorfon
treatment.
Table 5. Genetic effects induced by trichlorfon alone and by combined treatments.
Recovery No. of Corpora Preimplantation Live Postimplantation Tbtal
period, pregnant lutea Implants losses embryos losses mortality
days females per 9 per 9 per 9 % CL per 9 per 9 % Imp. per 9 % CL
- 68 9.15 9.93 0.78 7.9 8.78 0.37
1-7 11 10.18 9.36 0.82 8.0 9.18 0.18
8-14 11 9.73 8.46 1.27 13.1 8.37 0.09
15-21 40a 9.88 9.46 0.42 4.3 8.98 0.48
22-28 34a 9.56 8.15 1.41 14.8* 7.88 0.27
29-35 40a 10.35 9.22 1.13 10.9 8.97 0.25
36-42 14 9.00 7.93 1.07 11.9 7.36 0.57
43-49 14 10.50 9.43 1.07 10.2 9.36 0.07
Trichlorphon, 50 mg/kg + 1-7 13 9.77 8.69 1.08 11.0 8.15 0.54
methylparathion, 5 mg/kg 8-14 14 10.64 9.00 1.64 15.4* 8.64 0.36
15-21 13 10.77 9.46 1.31 12.1 8.85 0.61
22-28 9 11.00 10.22 0.78 7.1 10.00 0.22
29-35 40a 10.08 8.60 1.48 14.6* 8.43 0.17
36-42 31a 10.29 8.84 1.45 14.1 8.35 0.48
4349 44a 10.36 8.66 1.70 16.4 8.32 0.34
Trichlorfon, 50 mg/kg + 1-7 41a 10.41 8.44 1.98 19.0* 8.17 0.27
malathion, + 150 mg/kg 8-14 41a 10.24 8.49 1.76 17.1* 8.24 0.24
15-21 17 10.24 9.59 0.65 6.3 8.76 0.83
22-28 17 9.94 8.65 1.29 13.0 8.41 0.24
29-35 42a 10.55 8.83 1.71 16.3* 8.55 0.29
36-42 16 10.44 9.50 0.94 9.0 9.13 0.37
43_49 39a 9.79 8.28 1.51 15.5* 7.69 0.59
Trichlorfon, 50 mg/kg + 1-7 13 11.08 9.85 1.23 11.1 9.31 0.54
methylazinphos, 0.5 mg/kg 8-14 17 10.82 9.82 1.00 9.2 9.59 0.24
15-21 20 10.15 9.00 1.15 11.3 8.60 0.40
22-28 47a 10.45 8.60 1.85 17.7* 8.28 0.32
29-35 19 10.37 9.16 1.21 11.7 8.89 0.27
36-42 18 10.22 9.11 1.11 10.9 8.89 0.22
43-49 17 10.12 9.24 0.88 8.7 8.82 0.41
aData from two independent experiments.
*p < 0.01.
4.0 1.15
1.9 1.00
1.1 1.36
5.0 0.90
3.2 1.68
2.7 1.38
7.2 1.64
0.8 1.14
6.2 1.62
4.0 2.00
6.5 1.92
2.2 1.00
2.1 1.65
5.5 1.84
3.9 2.05
3.2 2.24
2.9 2.00
8.6 1.47
2.7 1.53
3.2 2.00
3.9 1.31
7.1 2.10
5.5 1.77
2.4 1.24
4.4 1.55
3.7 2.17
2.9 1.48
2.4 1.33
4.5 1.29
11.6
9.8
14.0
9.1
17.5
13.3
18.2
10.9
16.5
18.8
17.9
9.1
16.4
18.8
19.7
21.6
19.5
14.4
15.4
19.0
12.6
21.5
16.0
11.4
15.3
20.8
14.2
13.0
12.8
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Genetic Effects
The treatments did not induce male sterility and the
percentage of pregnant females was not affected. The
matings performed after combined trichlorfon-methyl-
parathion treatments gave a frequency of deciduomata
not significantly increased over the control level; the
number of live embryos per litter was always higher
than 8 (Table 5). At the same time, the preimplantation
lethality was important and averaged 1.46 losses per
female for the entire assay. Almost similar conclusions
could be drawn after trichlorfon-malathion combined
treatments. The postimplantation mortality was not
significantly enhanced, the number oflive embryos was
normal butthe preimplantation lethality was doubled as
compared to the control group (average of 1.56 losses
per female for the entire assay).
Except for the fourth mating week, the results
obtained after the trichlorfon-methylazinphos combined
treatments were negative. The only positive data con-
cerned once again an increase in the preimplantation
lethality without significant increase in the post-
implantation mortality or decrease in the size of the
litter.
However, when the results obtained with combined
treatments are compared to those observed fortrichlor-
fon treatment, only the preimplantation lethality in-
duced during the first and fifth weeks after the tri-
chlorfon-malathion combined treatment increase signi-
ficantly.
Discussion
It is of course difficult to compare the effects of a
single treatment of the maximum tolerated dose with
those obtained after combined treatments at 50% de-
creased doses.
Cytogenetic assays gave only negative results con-
firming those observed with the four single compounds
(5-8). Nointeractionwasobservedinthesetestsystems.
In the dominant lethal mutation assay, no increase of
the postimplantation fetal mortality occurred, and we
could not determine a mutagenic effect. Nevertheless,
the preimplantation losses were widely enhanced over
the control level.
But when compared to the single trichlorfon treat-
ment, only the trichlorfon-malathion treatment pro-
duced positive results. Since preimplantation lethality
could be correlated to a toxic effect on male germ cells,
this data confirms the increase in toxicity observed for
the preliminary toxicity test.
This research was performed under contract with the Belgian
Ministry of Public Health. The authors are grateful to Ms. Janice
Lynn Delaval for her help in rewriting this manuscript.
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